HomeInsights52 Week High Stocks

Aarti Drugs Ltd 52 Week High

Aarti Drugs Ltd 52 Week High

stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

5.3 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

YEARHIGH

634.9

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week HIGH of Aarti Drugs Ltd is ₹ 634.9 as of 18 Sep 24.

Company Fundamentals for Aarti Drugs Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024524.85
17 Sep 2024529.8
16 Sep 2024529.65
13 Sep 2024524.75
12 Sep 2024527.05
11 Sep 2024529
10 Sep 2024539.85
09 Sep 2024544.7
06 Sep 2024553.65
05 Sep 2024566.7

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Aarti Drugs Ltd

No data available

* All values are in crore

Aarti Drugs Ltd News Hub

News

Aarti Drugs extends buyback offer period

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday...

Read more

16 Sep 202408:52

News

Aarti Drugs AGM scheduled

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on...

Read more

03 Sep 202411:38

News

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up ...

Read more

26 Aug 202417:17

News

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Frida...

Read more

26 Aug 202416:35

News

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024...

Read more

22 Aug 202410:50

News

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billi...

Read more

22 Aug 202411:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Aarti Drugs Ltd

What is the significance of Aarti Drugs Ltd reaching its 52-week high?

Aarti Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Aarti Drugs Ltd 52-week high?

Investors monitor Aarti Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Aarti Drugs Ltd a good buy when it hits its 52-week high?

Whether Aarti Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Aarti Drugs Ltd fundamentals.

What should I consider before investing in Aarti Drugs Ltd at its 52-week high?

Before investing in Aarti Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Aarti Drugs Ltd stock price continue to rise after reaching its 52-week high?

Aarti Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*